Company Overview and News

 
Centuria Metro fund snaps up $119 million of new assets

2017-12-05 theage.com.au
Centuria Metropolitan REIT has expanded its footprint with the purchase of two new office assets for a combined $119.1 million, and will raise $60 million through an entitlement offer to provide some of the funding.

 
Centuria Metro fund snaps up $119 million of new assets

2017-12-05 smh.com.au
Centuria Metropolitan REIT has expanded its footprint with the purchase of two new office assets for a combined $119.1 million, and will raise $60 million through an entitlement offer to provide some of the funding.

 
Property trusts in race to reporting season

2017-07-14 theage.com.au
It has been a busy start to the new financial year with capital raisings, takeovers and flat trading conditions for some of the development-focused real estate investment trusts.

 
Property trusts in race to reporting season

2017-07-14 smh.com.au
It has been a busy start to the new financial year with capital raisings, takeovers and flat trading conditions for some of the development-focused real estate investment trusts.

 
Sydney fringe office markets in high demand

2016-08-26 theage.com.au
Metropolitan office markets are moving in on their city counterparts as the hot ticket in town for investment dollars.

 
Sydney fringe office markets in high demand

2016-08-26 smh.com.au
Metropolitan office markets are moving in on their city counterparts as the hot ticket in town for investment dollars.

 
GPT Metro board backs Centuria $317m offer

2016-06-22 smh.com.au
GPT Metro Office Fund's independent board has backed the sweetened cash and scrip offer made by Centuria​ Metropolitan REIT, which is valued at about $317 million.

 
Dividend/Distribution - CMA

2016-03-23 asx.com.au

 
 
CMA 1H16 Property Compendium

2016-02-19 asx.com.au

 
CMA Appendix 4D

2016-02-09 asx.com.au

 
Half Year Accounts

2016-02-09 asx.com.au

 
 

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...